Pubblicazioni

An integrative in-silico analysis discloses a novel molecular subset of colorectal cancer possibly eligible for immune checkpoint immunotherapy

2022 - BIOLOGY DIRECT

Sibilio, P.; Belardinilli, F.; Licursi, V.; Paci, P.; Giannini, G.

Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications

2022 - JOURNAL OF THE NATIONAL CANCER INSTITUTE

Moretto, R.; Elliott, A.; Zhang, J.; Arai, H.; Germani, M. M.; Conca, V.; Xiu, J.; Stafford, P.; Oberley, M.; Abraham, J.; Spetzler, D.; Rossini, D.; Antoniotti, C.; Marshall, J.; Shields, A.; Lopes, G.; Lonardi, S.; Pietrantonio, F.; Tomasello, G.; Passardi, A.; Tamburini, E.; Santini, D.; Aprile, G.; Masi, G.; Falcone, A.; Lenz, H. -J.; Korn, M.; Cremolini, C.